Polyribonucleotide containing deuterated nucleotides
Assigneeethris GmbH
InventorsCarsten Rudolph, Johannes Geiger, Sandra Hocke, Ludwig Weiss
Life of this patent
Estimating the term…
Abstract
The present disclosure provides polyribonucleotides, in particular polyribonucleotides, which comprise deuterated adenosine, cytidine, guanosine, and/or uridine residues and which show reduced immunogenicity and/or enhanced expression, and methods of using such polyribonucleotides for the therapy of diseases.
Claims16
An isolated polyribonucleotide comprising a sequence which encodes a protein, wherein at least 25% of each type of nucleotide selected from the group consisting of adenosine, cytidine, guanosine, and uridine is deuterated, wherein the expression of said polyribonucleotide is enhanced compared to a polyribonucleotide comprising the same sequence but without said deuterated nucleotides.
A method for preparing a polyribonucleotide comprising a sequence which encodes a protein, comprising using deuterated adenosine, cytidine, guanosine, and uridine nucleotides and modified forms thereof for the preparation of said polyribonucleotide, wherein said polyribonucleotide shows reduced immunogenicity and/or enhanced expression compared to a polyribonucleotide comprising the same sequence but without said deuterated nucleotides, wherein at least 25% of each adenosine, cytidine, guanosine, and uridine nucleotides are deuterated in the polyribonucleotide.
A method for reducing the immunogenicity and/or enhancing the expression of a polyribonucleotide comprising a sequence which encodes a protein, comprising:
- incorporating deuterated adenosine, cytidine, guanosine, and/or uridine residues within said polyribonucleotide, wherein said polyribonucleotide thus obtained displays reduced immunogenicity and/or enhanced expression compared to a polyribonucleotide comprising the same sequence but without said deuterated nucleotides, wherein at least 25% of each adenosine, cytidine, guanosine, and uridine nucleotides are deuterated in the polyribonucleotide.
An isolated polyribonucleotide comprising a sequence which encodes a protein, wherein at least 25% of at least two types of nucleotides selected from the group consisting of adenosine, cytidine, guanosine, and uridine are deuterated, wherein the expression of said polyribonucleotide is enhanced compared to a polyribonucleotide comprising the same sequence but without said deuterated nucleotides.
Dependencies are inferred from the claim text.